Session Details
[1-YIA]YIA-PD
Mon. Mar 16, 2026 8:45 AM - 10:00 AM JST
Mon. Mar 16, 2026 11:45 PM - 1:00 AM UTC
Mon. Mar 16, 2026 11:45 PM - 1:00 AM UTC
Room 7(B203)
Chair:Hideki Amano(Kitasato University School of Medicine), Koh Nakayama(Asahikawa Medical University)
[1-YIA-01]The amplification interaction between calcium release modes in skeletal ryanodine receptors
*Yoshifumi Stephen Miki1, Jun Tanihata2, Takayoshi Inoue3, Yukiko U. Inoue3, Satoru Noguchi4, Takashi Murayama5, Toshiko Yamazawa1,6 (1. Tokyo Jikei University School of Medicine Core Research Facilities, 2. Tokyo Jikei University School of Medicine, Department of Molecular Physiology, 3. Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4. Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 5. Juntendo University School of Medicine, Department of Pharmacology, 6. Center for Systemic Intelligence in Biomedicine)
[1-YIA-02]H-PGDS-targeted PROTAC is a new medication for allergic rhinitis
*Noriko Ozaki1, Nanae Nagata1, Kosuke Aritake2, Yosuke Demizu3,4,5, Yuki Sugiura6, Mitsuhiro Okano7, Marie Yamada7, Tatsuo Shimosawa8, Takahisa Murata1,9,10 (1. Anim. Radiol. Vet. Pharmacol., Tokyo Univ., 2. Daiichi Univ. of Pharm., 3. Grad. Sch. Med., Dent. & Pharm. Sci., Div. Pharm. Sci.,Okayama Univ., 4. Grad. Sch. Med. Life Sci., Yokohama City Univ., 5. Natl. Inst. of Health Sci., 6. Sch. Med., Kyoto Univ., 7. Dept. Otorhinolaryngol., Int. Univ. of Health & Welfare, 8. Dept. Clin. Lab., Int. Univ. of Health & Welfare, 9. Vet. Pharmacol., Tokyo Univ., 10. Food Anim. Syst., Tokyo Univ.)
[1-YIA-03]Development of a novel anti-EphA4 monoclonal antibody for various applications
*Guanjie Li1, Tomohiro Tanaka1, Mika Kaneko1, Hiroyuki Suzuki1, Yukinari Kato1 (1. Tohoku University)
[1-YIA-04]Aquaporin-5 regulates mitochondrial activity.
*Shin-ichi Muroi1, Mai Kanai2, Kosuke Kusamori3, Yoichiro Isohama1 (1. Lab. Appl. Pharmacol., Fac. Pharm. Sci., Tokyo Univ. of Sci., 2. Lab. Biopharmaceutics, Fac. Pharm. Sci., Tokyo Univ. of Sci., 3. Lab. Cellular Drug Discovery and Development, Fac. Pharm. Sci., Tokyo Univ. of Sci.)
[1-YIA-05]Assessment of MEK inhibitor-induced cardiac contractile dysfunction using human iPSC-derived cardiomyocytes.
*Shota Yanagida1, Hiroyuki Kawagishi1, Yasunari Kanda1 (1. National Institute of Health Sciences)
